Latest

Low-Dose Naltrexone Is Not a Rescue Medication: Setting Realistic Expectations for a Regulatory and Modulatory Therapy

Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Introduction Low-dose naltrexone (LDN) has gained increasing recognition as a valuable tool in integrative and functional medicine, particularly for chronic inflammatory, autoimmune, and neuroimmune conditions. However, as clinical interest in LDN has grown, so

By Yoon Hang Kim MD
Evaluating Surgical and Integrative Oncology Options in Early-Stage Breast Carcinoma with Favorable Histology and Multiple Lesions

Evaluating Surgical and Integrative Oncology Options in Early-Stage Breast Carcinoma with Favorable Histology and Multiple Lesions

A Case-Based Review of Attributable Benefit, Attributable Risk, and the Role of Integrative Strategies Alongside Definitive Treatment Yoon Hang Kim, MD, MPH  •  Board-Certified in Preventive Medicine  |  Integrative & Functional Medicine Physician Introduction When a client presents with a new diagnosis of early-stage breast carcinoma, two sets of

By Yoon Hang Kim MD
Low-Dose Naltrexone and Prolactin:What Clinicians Should Know About an Emerging Question

Low-Dose Naltrexone and Prolactin:What Clinicians Should Know About an Emerging Question

Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician www.directintegrativecare.com Introduction As low-dose naltrexone (LDN) prescribing grows across integrative, functional, and conventional medicine settings, clinicians are occasionally encountering an unexpected laboratory finding: a mildly elevated serum prolactin in a client taking

By Yoon Hang Kim MD

MCAS

The Layered Approach to Mast Cell Activation Syndrome: Integrating Dr. Afrin’s Framework with Functional Medicine Therapeutics

www.directintegrativecare.com A Clinical Chapter on Trigger Avoidance, Anaphylaxis Preparedness, Antihistamines, Stabilizers, Antileukotrienes, Omalizumab, LDN, Quercetin, Luteolin, and Methylene Blue in a Stepwise Model Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Abstract Mast Cell Activation Syndrome (MCAS) is a multi-system

By Yoon Hang Kim MD
The Layered Approach to Mast Cell Activation Syndrome: Integrating Dr. Afrin’s Framework with Functional Medicine Therapeutics

The Layered Approach to Mast Cell Activation Syndrome: Integrating Dr. Afrin’s Framework with Functional Medicine Therapeutics

www.directintegrativecare.com A Clinical Chapter on Trigger Avoidance, Anaphylaxis Preparedness, Antihistamines, Stabilizers, Antileukotrienes, Omalizumab, LDN, Quercetin, Luteolin, and Methylene Blue in a Stepwise Model Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Abstract Mast Cell Activation Syndrome (MCAS) is a multi-system

By Yoon Hang Kim MD

FMT

Fecal Microbiota Transplantation (FMT): Not Just a Probiotic — And Not Available Over the Counter

Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Medical Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Fecal microbiota transplantation is a regulated medical therapy—do not attempt this outside a supervised

By Yoon Hang Kim MD
Can EBOO Cause Blood Clots? Evaluating the Thrombotic Risk of Extracorporeal Blood Oxygenation and Ozonation

Can EBOO Cause Blood Clots? Evaluating the Thrombotic Risk of Extracorporeal Blood Oxygenation and Ozonation

Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Introduction: A Question Worth Asking Honestly Extracorporeal Blood Oxygenation and Ozonation (EBOO) has gained significant traction in integrative and functional medicine. Blood is drawn from one vein, passed through a hollow-fiber dialysis-style cartridge

By Yoon Hang Kim MD
THE THERAPEUTICS OF HEAT: Thermogenesis, Hyperthermia, and Heat-Delivered Therapy from Antiquity to Evidence-Based Medicine

Heat as Medicine

THE THERAPEUTICS OF HEAT: Thermogenesis, Hyperthermia, and Heat-Delivered Therapy from Antiquity to Evidence-Based Medicine

A Monograph for the Integrative Clinician Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine Integrative & Functional Medicine Physician Medical Disclaimer: This monograph is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Heat-based interventions carry real risks including burns, scarring, infection, cardiovascular

By Yoon Hang Kim MD
ApoB/ApoA1 Ratio vs. NMR LDL Particle Number: Which Lipid Marker Actually Predicts Your Cardiovascular Risk?

apo b lipid particle

ApoB/ApoA1 Ratio vs. NMR LDL Particle Number: Which Lipid Marker Actually Predicts Your Cardiovascular Risk?

www.directintegrativecare.com ApoB/ApoA1 Ratio vs. NMR LDL Particle Number: Which Lipid Marker Actually Predicts Your Cardiovascular Risk? A comparative clinical review of two advanced lipid markers — and why the choice between them matters more than most standard cholesterol panels reveal. MEDICAL DISCLAIMER This article is for educational purposes

By Yoon Hang Kim MD